There was some earlier conjecture on the size of the market and potential annual future sales for ReCell re: interview with Bill Dolphin. Re-listening to the interview, Dolphin discusses the different market segments which ReCell is targeting - chronic wounds, burns and cosmetic applications e.g. wrinkles, acne scarring.
"We can see that, on the order of 10-12 million procedures will be done per year utilising ReCell," said Dolphin.
The number of ReCell kits which Dolphin can visualize being sold is 10-12 million annually. Assuming a sales value per kit of $750, Dolphin is projecting a future turnover of $7.5B. Of course the future could be 5-15 years away. The sheer scale of the market and the revolutionary impact of the ReCell procedure will - at some point in time - make Avita Medical a hotly contested takeover target. Of course, as Dolphin appears to suggest in the interview - that's the whole point.
- Forums
- ASX - By Stock
- AVH
- onemedplace video
onemedplace video, page-42
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.73 |
Change
-0.200(6.83%) |
Mkt cap ! $185.9M |
Open | High | Low | Value | Volume |
$2.70 | $2.77 | $2.63 | $1.420M | 521.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3075 | $2.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.73 | 45063 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3075 | 2.710 |
6 | 24399 | 2.700 |
1 | 5576 | 2.690 |
1 | 111 | 2.680 |
3 | 2744 | 2.670 |
Price($) | Vol. | No. |
---|---|---|
2.730 | 45063 | 1 |
2.790 | 12945 | 2 |
2.820 | 2000 | 1 |
2.880 | 500 | 1 |
2.910 | 4250 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |